True to our local roots, we are able to form a great bond with our patients and provide continuous encouragement to them throughout their weight loss journey to reach their goals
Clinical Applications While human trials are limited and 5-Amino-1MQ is not FDA-approved as a therapeutic agent, its mechanism and early research suggest potential benefits in: Weight management and body recomposition Adiposity reduction and fat loss Insulin sensitivity improvement Metabolic syndrome support NAD optimization and anti-aging protocols Cellular energy and endurance enhancement Adjunct to exercise or caloric restriction protocols It may be particularly relevant for individuals with stubborn fat loss resistance , age-related metabolic decline, or those using NAD-supportive therapies like NMN or NR
Tseng, A
Some patients, upon experiencing reduced appetite initially, may later develop patterns of eating more calorie-dense foods during periods when they do feel hungry
Obstructive sleep apnea and psychiatric disorders: a systematic review
The general consensus, as highlighted in the recent consensus statement from the Association of Anaesthetists (9th January 2025), is that, with proper risk assessment and planning, these medications do not have to be stopped before surgery
